Product Information
OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Strides Pharma Inc., priced at $0.1575 per ML under NDC 64380087975. Its NADAC has been published 143 times since Nov 30, 2022.
FDA first approved this application on Jan 13, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
6 mg/mL
Manufacturer
Strides Pharma Inc.NDC
64380087975
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA211894FDA Approved
1/13/2022
TE Code
AB
On Market Since
10/24/2022
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 143 times since Nov 30, 2022, and over the history we have for it it has declined 60.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1575 per ML |
|---|---|
| All-time high | $0.3998 (Dec 14, 2022) |
| All-time low | $0.1271 (Nov 20, 2024) |
| 52-week high | $0.1739 |
| 52-week low | $0.1497 |
| Median price | $0.1982 |
| Average price | $0.2178 |
| Largest weekly change | +38.5% (Dec 18, 2024) |
| Weeks tracked | 143 |
| Tracking since | Nov 30, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
+3.7%
1Y
-7.4%
3Y
-53.5%
5Y
N/A
All
-60.6%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Strides Pharma Inc., is $0.1575 per ML (NDC 64380087975), effective May 20, 2026.
How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 60.6%. It has been tracked across 143 weekly CMS publications since Nov 30, 2022.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?
Since Nov 30, 2022, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $0.3998 (Dec 14, 2022), with a median of $0.1982 per ML.
Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OSELTAMIVIR 6 MG/ML SUSPENSION, is $0.1511 per ML — about 4% below OSELTAMIVIR 6 MG/ML SUSPENSION.
Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?
OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 64380087975) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.